This month’ case highlights the treatment of a bifurcation lesion in a 70 years old female patient, ex-smoker, known to have essential hypertension and chronic obstructive lung disease. The patient reports exertional palpitations for which a coronary computed tomography angiography showed a left anterior descending (LAD) lesion and a Holter ECG multiple ventricular extrasystoles. She also is scheduled for elective surgery.
Coronary angiography pre-TAVR revealed: Severe proximal LAD bifurcation lesion with a relatively small diagonal in an acute angle that covers an important an important territory, Medina (1,1,1).
Educational objectives
-
How to treat a bifurcation lesion
-
Plan a step-by-step approach procedure for bifurcation lesions with a bail-out strategy
-
Role of drug coated balloons in bifurcation lesions
-
Lesion preparation using a scoring balloon
-
Avoiding intimal disruption and side branch occlusion
Step-by-step procedure:
1) Access site:
-
Right radial approach: 6 French EBU 3.5 6 French to the left main.
-
Anticoagulation using heparin.
2) Lesion preparation:
-
Two 0.014” workhorse guidewires were introduced into the LAD and the diagonal respectively.
-
Using the two markers of a non-compliant balloon, calcifications could be seen using enhanced stent imaging.
-
The balloon is inflated at moderate pressure (13 atm) for a longer time in order to undergo a controlled angioplasty and preserve intimal integrity by avoiding dissections.
3) Calcium modification device (scoring balloon):
-
Angiographic assessment of the lesion showed the need for a further dilation using a Calcium modification device.
-
A 2.5 x 13 mm scoring balloon (NSE Alpha) was inflated at 8 atm in order to disrupt the lesion calcium.
4) Treatment decision for the LAD lesion : DCB or DES ?
With the risk of losing the diagonal branch by stenting the LAD, a bail out DK-Crush or V-Stenting techniques could be used. A Drug Coated Balloon would therefore overcome this caging affect as well as the need for longer dual antiplatelet therapy.
A 2.5 x 15 mm Sirolimus drug coated balloon SeQuent SCB was inflated to 10 atm during 45 seconds. Further lesion work or intracoronary imaging should be avoided in order not to disrupt the implanted coating unless a dissection is present.
Final angiographic end-result showed a satisfactory LAD result with the diagonal branch preserved.
Phone call follow-up after 3 months : the patient is fine
Bibliography
1. Corballis, N.H.; Paddock, S.; Gunawardena, T.; Merinopoulos, I.; Vassiliou, V.S.; Eccleshall, S.C. Drug Coated Balloons for Coronary Artery Bifurcation Lesions: A Systematic Review and Focused Meta-Analysis. PLoS One 2021, 16, 1–10, doi:10.1371/journal.pone.0251986.
2. Muramatsu, T.; Kozuma, K.; Tanabe, K.; Morino, Y.; Ako, J.; Nakamura, S.; Yamaji, K.; Kohsaka, S.; Amano, T.; Kobayashi, Y.; et al. Clinical Expert Consensus Document on Drug-Coated Balloon for Coronary Artery Disease from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc. Interv. Ther. 2023, 38, 166–176, doi:10.1007/s12928-023-00921-2.
3. Scheller, B.; Mangner, N.; Abdul Kader, M.A.S.K.; Wan Ahmad, W.A.; Jeger, R.; Wöhrle, J.; Ong, T.K.; Liew, H.B.; Gori, T.; Mahfoud, F.; et al. Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions. Circ. Cardiovasc. Interv. 2022, 15, E012305, doi:10.1161/CIRCINTERVENTIONS.122.012305.
4. de la Torre Hernandez, J.M.; Puri, R.; Alfonso, F. Drug-Coated Balloon: “Scoring to Win.” JACC Cardiovasc. Interv. 2017, 10, 1341–1343, doi:10.1016/j.jcin.2017.05.019.
Date du tournage : 01/03/2024
Dernière mise à jour : 05/03/2024
Joshua W. Very interesting case.